Table 1.
Baseline characteristics (n = 5297)
| Characteristic | Never HF (n = 4947) | Incident HF (n = 350) | Subgroups of incident HF | |
|---|---|---|---|---|
| MI‐related HF (n = 99) | Non‐MI‐related HF (n = 251) | |||
| Age | 69.1 ± 6.2 | 72.5 ± 5.9 | 71.8 ± 5.1 | 72.8 ± 6.2 |
| Male, n (%) | 3410 (68.9) | 278 (79.4) | 85 (85.9) | 193 (76.9) |
| Smokers, n (%) | 967 (19.5) | 75 (21.4) | 28 (28.3) | 47 (18.7) |
| Systolic blood pressure (mmHg) | 145.8 ± 20.5 | 148.4 ± 21.5 | 146.8 ± 21.8 | 149.1 ± 21.5 |
| Diastolic blood pressure (mmHg) | 84.0 ± 10.70 | 83.2 ± 10.99 | 81.2 ± 11.87 | 84.0 ± 10.55 |
| Diabetes, n (%) | 714 (14.4) | 83 (23.7) | 27 (27.3) | 56 (22.3) |
| LDL‐C a (mmol/L) | 3.63 ± 0.99 | 3.37 ± 0.98 | 3.12 ± 0.99 | 3.47 ± 0.95 |
| HDL‐C b (mmol/L) | 1.38 ± 0.40 | 1.35 ± 0.42 | 1.31 ± 0.38 | 1.36 ± 0.43 |
| BMI c (kg/m2) | 27.1 ± 4.1 | 28.1 ± 4.9 | 27.9 ± 4.4 | 28.2 ± 5.0 |
| Creatinine (μmol/L) | 96.1 (27.3) | 106.3 (29.9) | 109.5 (32.1) | 105.1 (29.0) |
| Copeptin d (pmol/L) | 6.99 (4.24–11.53) | 9.28 (5.36–16.53) | 8.57 (5.67–17.41) | 9.35 (5.10–15.99) |
| Antihypertensive treatment, n (%) | 1866 (37.7) | 216 (61.7) | 76 (76.8) | 140 (55.8) |
| Lipid‐lowering treatment, n (%) | 927 (18.7) | 122 (34.9) | 51 (51.5) | 71 (28.3) |
All values are given as mean (standard deviation) if nothing else specified.
HF, heart failure; MI, myocardial infarction.
a
Low‐density lipoprotein cholesterol.
b
High‐density lipoprotein cholesterol.
c
Body mass index.
d
Median (25th percentile; 75th percentile).